Conexa Saude is a technology company.
Conexa Saude has raised $8.0M across 1 funding round.
Conexa Saude has raised $8.0M in total across 1 funding round.
Conexa Saude has raised $8.0M in total across 1 funding round.
Conexa Saude's investors include Igah Ventures.
Conexa Saúde is a Brazilian digital health platform specializing in telemedicine, connecting patients with healthcare professionals across over 30 medical specialties through online consultations, 24/7 virtual urgent care, and personalized health programs.[1] It primarily serves corporations, health insurance providers, and individual patients by addressing accessibility and efficiency challenges in healthcare, enabling organizations to cut costs and boost employee well-being via integrated solutions; the company generates revenue through corporate subscriptions, health plan fees, and per-consultation charges.[1] Founded in 2017 and based in São Paulo (with some sources noting Rio de Janeiro operations), it has raised over $50M in funding, employs around 492 people, and reports annual revenue between $10M-$25M.[1][2]
Conexa Saúde was founded in 2017 in São Paulo, Brazil, amid rising demand for accessible healthcare in a country with geographic and systemic barriers to medical services.[1] While specific founders are not detailed in available sources, the company's emergence aligns with the global telemedicine boom, focusing on preventive medicine and technology to shorten distances, foster medical networking, and democratize care nationwide.[3] Early traction likely stemmed from its mobile-friendly platform for patient consultations and partnerships with clinics, hospitals, and corporations for employee health solutions, leading to substantial funding—totaling $38M to $52.89M across rounds—and rapid scaling to nearly 500 employees.[1][4]
Conexa Saúde rides the telemedicine wave accelerated by the COVID-19 pandemic and Brazil's healthcare disparities, where vast geography and overburdened public systems create demand for digital alternatives.[1][3] Its timing capitalizes on regulatory shifts favoring telehealth and rising corporate wellness investments, with market forces like healthtech adoption (projected to grow rapidly in Latin America) working in its favor.[4] By providing B2B tools for insurers and employers alongside consumer access, it influences Brazil's ecosystem by lowering barriers, promoting preventive care, and enabling scalable health management amid aging populations and cost pressures.
Conexa Saúde is poised for expansion through deeper B2B penetration, potential international telemedicine plays, and AI-enhanced personalization amid Brazil's digital health surge. Trends like regulatory telehealth permanence and corporate ESG health mandates will shape its path, potentially elevating its influence as a regional leader in accessible care. This positions it to build on its $50M funding war chest for sustained momentum in democratizing healthcare.
Conexa Saude has raised $8.0M across 1 funding round. Most recently, it raised $8.0M Series B in June 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2020 | $8.0M Series B | Igah Ventures |